In current diagnostic systems, schizophrenia and bipolar disorder are still conceptualized as distinct categorical entities. Recently, both clinical and genomic evidence have challenged this Kraepelinian dichotomy. There are only few longitudinal studies addressing potential overlaps between these conditions. Here, we present design and first results of the PsyCourse study (N 5 891 individuals at baseline), an ongoing transdiagnostic study of the affective-to-psychotic continuum that combines longitudinal deep phenotyping and dimensional assessment of psychopathology with an extensive collection of biomaterial. To provide an initial characterization of the PsyCourse study sample, we compare two broad diagnostic groups defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) classification system, that is, predominantly affective (n 5 367 individuals) versus predominantly psychotic disorders (n 5 524 individuals). Depressive, manic, and psychotic symptoms as well as global functioning over time were contrasted using linear mixed models. Furthermore, we explored the effects of polygenic risk scores for schizophrenia on diagnostic group membership and addressed their effects on nonparticipation in follow-up visits. While phenotypic results confirmed expected differences in current psychotic symptoms and global functioning, both manic and depressive symptoms did not vary between both groups after correction for multiple testing. Polygenic risk scores for schizophrenia significantly explained part of the variability of diagnostic group. The PsyCourse study presents a unique resource to research the complex relationships of psychopathology and biology in severe mental disorders not confined to traditional diagnostic boundaries and is open for collaborations. In addition, there is extensive overlap of symptoms between schizophrenia (SZ) and bipolar disorder (BD) as observed in clinical day-to-day reality (Murray et al., 2004) . Traditional categorical nosological systems have therefore been fundamentally challenged during the past years.
Alternative concepts of hierarchically and dimensionally measured phenotypes have been put forward by the NIMH Research Domain Criteria (RDoC; Insel et al., 2010) and the Hierarchical Taxonomy of Psychopathology (HiTOP; Kotov et al., 2017) , the former emphasizing the need for biologically informed domains early on. To this end, genetics have often played an important role in redefining psychiatric diagnoses (Robins & Guze, 1970) . More recently, findings regarding an overlapping but distinct genetic basis of SZ and BD in both family (Lichtenstein et al., 2009 ) and molecular genetic studies (CrossDisorder Group of the Psychiatric Genomics Consortium, 2013; Forstner et al., 2017; Purcell et al., 2009) , have accelerated the momentum toward dimensionally defined diagnosis (Craddock & Owen, 2010) of severe mental disorders. Even though spectrum phenotypes have been introduced in the DSM-5 in the areas of autism and substance use, this modern diagnostic approach has not been applied to SZ and BD. However, as outlined above, there are several compelling reasons for the introduction of a psychosis spectrum disorder (for a detailed discussion see Guloksuz & van Os, 2017) . There is thus a pressing need to incorporate this biological information into future diagnostic systems.
Against this background, addressing two important issues might pave the way for a successful research into this matter: First, longitudinal research is necessary to capture variation over time. Pronounced heterogeneity in the longitudinal course of both SZ (e.g., Carpenter & Kirkpatrick, 1988; Heilbronner, Samara, Leucht, Falkai, & Schulze, 2016) and BD (e.g., Angst, 1978) exists. Overlap of symptoms, comorbidity and instability of diagnoses over time occur frequently in everyday clinical practice. Thus, just as subtypes of traditionally defined nosological categories emerged by examining their clinical course (e.g., Bleuler, 1968) , similarities and differences between traditionally defined SZ and BD may emerge when a combination of biological information and clinical course is considered. While only few modern longitudinal studies of severe mental illnesses exist, the longitudinal course of affective disorders, such as BD, has received particularly little attention to date (Pfennig et al., 2017 ). Second, a major emphasis on phenomics is needed, "the systematic study of phenotypes on a genome-wide scale" (Bilder et al., 2009 ). In an age in which genomic and other high-throughput data can be obtained relatively inexpensively and rapidly, a major challenge is to obtain extensive high-quality phenotype data. Such data are required to establish meaningful genotype-phenotype relationships, and will ultimately lead to biologically informed patient stratification (Kapur, Phillips, & Insel, 2012) .
The aim of this communication is to introduce the PsyCourse study, a longitudinal study of severe mental disorders on the affectiveto-psychotic continuum, which aims to address these issues. Deep phenotyping is combined with an extensive collection of biological material at every measurement point, enabling the combination of multilevel omics and longitudinal clinical data. Specifically, current symptomatology, cognitive status, and self-report measures are assessed at every measurement point, interspersed with the collection of relevant crosssectional data (see Supporting Information Table 1 ).
Here, we provide an initial characterization of the PsyCourse study sample. First, we present longitudinal data on positive, depressive, and manic symptoms as well as data on global psychosocial functioning of the clinical participants of the PsyCourse study. We compare these variables between two broad diagnostic groups within the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) framework, defined as psychotic and affective, by their predominant symptoms. In addition, as proof of principle of the PsyCourse sample's potential for genomic analyses, we use polygenic risk scores (PRS) for SZ (SZ-PRS) for a first biological characterization of these diagnostic groups. PRS are a method for estimation of the polygenic load of common risk alleles an individual carries for a certain trait or disorder (Purcell et al., 2009 ); for overview see Wray et al. (2014;  in this case for SZ). Findings from PRS analyses support the notion of both overlapping (Purcell et al., 2009 ) and specific (Ruderfer et al., 2014) genetic backgrounds of SZ and BD as well as the continuum model of psychosis (Tesli et al., 2014) . To study genetic overlap between disorders by means of PRS, it is usually analyzed whether PRS for one disorder, for example, SZ, can successfully predict case-control status for other traits, for example BD (Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013; Purcell et al., 2009) . Another approach, focusing on the specific genetic backgrounds of SZ and BD, was used by Ruderfer et al. (2014) who created a PRS for the discrimination between SZ and BD. Here, we used SZ-PRS because the available discovery genome-wide association study (GWAS) comparing SZ patients and controls is based on a substantially larger sample (N 5 36,989 patients vs. N 5 113,075 controls; Ripke et al., 2014) than the largest published GWAS comparing BD and controls (N 5 13,902 patients vs. N 5 19,279 controls; Charney et al., 2017) . Unlike the studies described above, we directly explore to what extent SZ-PRS can differentiate between two groups of patients in the PsyCourse study, predominantly psychotic and affective participants. As longitudinal research inevitably leads to attrition, selective dropout of subgroups of study participants is a major challenge. This is especially important as it is well-known that demographic variables like age, sex, socioeconomic status as well as emotional and behavioral problems are associated with attrition (de Graaf, van Dorsselaer, Tuithof, & ten Have, 2013; Wolke et al., 2009) . Notably, a recent study found higher SZ-PRS to be associated with nonparticipation over time in a population-based cohort study (Martin et al., 2016) . Therefore, we also present analyses Study participants are assessed at four points in time, in intervals of 6 months, hereafter referred to as study visits 1 (T1; baseline), 2 (T2; 16 months), 3 (T3; 112 months), and 4 (T4; 118 months). Additional visits should be conducted for clinical participants if they are readmitted for inpatient treatment during the study period. Importantly, participating individuals are allowed to miss one or more follow-up study visits without being excluded from the study. At each study visit, venous blood samples are collected, permitting extraction of biomaterials such as DNA, RNA, plasma, and serum. In addition, a comprehensive set of phenotype data is collected, assessing symptom dimensions, cognitive function, and self-report measures (Supporting Information Angermeyer, Kilian, & Matschinger, 2000; Army Individual Test Battery, 1944; Aster, Neubauer & Horn, 2006; McGuffin, Farmer, & Harvey, 1991; Grabe et al., 2012; Grof et al., 2002; Hautzinger, Keller, & Kühner, 2006; Helmstaedter, Lendt, & Lux, 2001; Kay, Fiszbein, & Opler, 1987; Konings, Bak, Hanssen, van Os, & Krabbendam, 2006; Krüger, Bräunig, & Shugar, 1997; Lehrl, 2005; Margraf, 1994; McGuffin, Farmer, & Harvey, 1991; National Institute of Mental Health, 1976; Norbeck, 1984; Rammstedt & John, 2007; Rush, Carmody, & Reimitz, 2000; Stefanis et al., 2002; Ware, Kosinski, & Keller, 1996; Wittchen & Fydrich, 1997; Young, Biggs, Ziegler, & Meyer, 1978 whereas those with a life-time DSM-IV diagnosis of BD (296.0x/ 296.4x/296.5x/296.6x/296.8x) or reMDD (296.3x) constitute the predominantly affective group. If none of the above DSM-IV diagnoses can be ascertained, clinical participants are excluded from the study.
Participants must be proficient in German language to enroll in the study.
| Nonclinical (control) participants
Inhabitants of the catchment areas of G€ ottingen and Munich are contacted either by mail, based on address lists acquired from the local Residents' Registration Office, or by advertisements in public areas and are invited to participate in the study. Individuals must be proficient in German language to enroll in the study. Those included in the study follow a similar protocol as the clinical participants (see Supporting Information Table 1 ). History of affective or psychotic illness is assessed using a short diagnostic interview for mental disorders (Margraf, 1994) .
| Broad informed consent
Before study participation, written informed consent is obtained from study participants. A special broad informed consent is required from participants, as the exact research objectives are not specified and both phenotypic data and biomaterial are to be stored until they are no longer useful for research (German National Ethics Council, 2004) . According to European and German law, such broad informed consent is only possible if special data protection measures are taken to shield personal data from unauthorized access (see Section 2.1.5 on data protection).
Participating individuals must explicitly agree to these measures, if they want to participate in the study. In addition, potential participants must decide whether they want to be informed about possible incidental findings that the study may uncover. Collaboration with nonpsychiatric research disciplines and the possibility to jointly analyze data together with other researchers or research consortia is explicitly allowed, albeit only using pseudonymized data. Furthermore, participants are asked to release medical facilities involved in their prior treatment from doctorpatient confidentiality, so that information on their past medical records can be obtained. This serves as an additional source of information on their medical history.
| Opt-out
If a participant decides to opt-out after enrolling in the study, two options exist:
1. Disposal of the participant's biomaterial and permanent deletion of all phenotypic data, or 2. All information collected until that point in time will be retained but irreversibly anonymized.
Data that are already part of scientific analyses at the time of the optout may be used further, regardless of the opt-out, albeit only in anonymized form.
| Data protection
As we collect sensitive phenotypic data and biomaterials, a data protection concept was developed (Demiroglu et al., 2012) 3. The phenotype database, containing information collected using rating scales, questionnaires, and cognitive tests. 
| Interviewers
Interviewers are provided with instructions in written form for all instruments and each new interviewer is extensively trained in administering the phenotyping battery by an experienced interviewer. Depending on interviewer experience, training includes discussing the instructions in detail, watching an experienced investigator conducting a visit and performing a visit under supervision of the latter. In addition, trainings for all investigators are held on a regular basis.
| Biological-psychiatric analyses in the PsyCourse resource
Clinical data presented herein are from a snapshot of the phenotype database taken on September 19th, 2016 and include a total of 891 clinical participants. Regarding biomaterial, venous blood samples were collected at each study visit. Briefly, DNA, RNA, and plasma and serum samples were prepared using standard methods. Data were analyzed using R (www.r-project.org, version 3.3.2), and SPSS (IBM, version 24).
| Phenotype analyses
Cross-sectional phenotype data were analyzed with Pearson's chisquared and t tests, depending on the type of data (see Table 1 ). Longitudinal data were analyzed using linear mixed-effect regression (R package lme4; Bates, Maechler, Bolker, & Walker, 2014) . The variables age at first study visit, psychiatric treatment at first study visit (ordinal variable with levels "outpatient/no psychiatric treatment" and "in-or day patient"), sex, group, and time as well as interactions between sex, group, and time entered the model as fixed effects. Subject and clinical center of the first study visit were modeled as random intercept effects. To fulfill the requirement of normally distributed residuals, we transformed data of the inventory of depressive symptomatology (IDS-C 30 ), the young mania rating scale (YMRS) and the positive and negative syndrome scale (PANSS) positive score using the natural logarithm.
Subsequent visual inspection of the residuals of each model did not
show any obvious deviation from normality. The ANOVA function in the R lmerTest package (Kuznetsova, Brockhoff, & Christensen, 2016) was used to obtain p-values for fixed effects using Satterthwaite's approximation of degrees of freedom. p-Values of the four linear mixed-effect models were false discovery rate (FDR) corrected to account for Type-I error cumulation resulting from multiple comparisons. A coefficient of determination (R 2 ) was calculated for each model with the R r2glmm package (https://github.com/bcjaeger/r2glmm) using the Nakagawa and Schielzeth (2013) method.
| Genotyping and imputation of genetic data
DNA samples of 825 clinical participants were genotyped using the Illumina Infinium PsychArray (Illumina), yielding information for approximately 590,000 genetic markers. More than 10% of these markers are in genetic loci previously associated with neuropsychiatric disorders.
After standard quality control procedures, genotype imputation was performed using SHAPEIT2 (https://mathgen.stats.ox.ac.uk/genetics_ software/shapeit/shapeit.html) and IMPUTE2 (http://mathgen.stats.ox.
ac.uk/impute/impute_v2.html; Andlauer et al., 2016; Delaneau, Zagury, & Marchini, 2012; Howie, Donnelly, & Marchini, 2009 , sex 3 age interaction as well as the first five ancestry principal components, were entered in the first block. In the second block, the predictor of interest, the respective z-standardized SZ-PRS, was added. The reported estimates of change in R 2 represent the gain in Nagelkerke's R 2 by adding SZ-PRS to the model.
| Analyses of follow-up study participation
As described in Section 2.1, study participants are allowed to miss one or more follow-up study visits without being excluded from the study.
To address the question of selective dropouts in the PsyCourse study, subjects with baseline data only, hereafter referred to as the dropout group, were compared to subjects with follow-up data for at least one timepoint within the 18-month study period, hereafter referred to as the follow-up group. To assure a valid assignment to these groups in the ongoing project, the study period of 18 months plus an additional time of 5 months for data entry were considered. Since the export from the database was carried out on September 19th, 2016, only subjects with a T1 before October 19th, 2014 were selected for these analyses (N 5 678).
Logistic regression (forced entry method) was used to test the effects of the following phenotypic predictors on group-membership (dropout group vs. follow-up group): sex, age at baseline, age2, age 3 sex interaction, center, diagnosis, educational status, psychiatric treatment at baseline, duration of illness, PANSS positive score, PANSS negative score, PANSS general score, IDS-C 30 sum score, YMRS sum score and global assessment of functioning (GAF). In a second step, blockwise logistic regression analyses were performed to estimate the effects of SZ-PRS for 11 different pvalue thresholds, as explained above. Ancestry principal components were calculated specifically for the subsample entering these analyses (for methods see Section 2.2.3) in order to be able to correct for potential effects of population substructure. The significant phenotypic predictors from the previous analyses, namely sex, sex 3 age interaction and psychiatric treatment at baseline, as well as the first five ancestry principal components were entered as covariates in the first block. In the second block, the respective z-standardized SZ-PRS was added as a predictor. Estimates of change in Nagelkerke's R 2 relative to the SZ-PRS are reported.
| RE S U L TS
Here, we report data of a total of N 5 891 clinical individuals that were included in the study at baseline (first study visit; T1). Of these N 5 891 individuals, 526 (59.0%), 415 (46.6%), and 351 (39.4%) completed the second, third, and fourth study visit, respectively. Importantly, individuals can miss one or more follow-up study visits without being excluded from the study. In such cases, individuals were recontacted again before the next scheduled appointment and invited to continue to participate in the study. Also the numbers above represent a snapshot of the phenotype database taken on the September 19th,
2016. This means that study participants might still be enrolled in the study at that time and complete further study visits.
We compare clinical groups with predominantly affective symp- Table 2 .
| Phenotypic analyses
Cross-sectional comparisons on demographic variables between the two groups are summarized in Table 1 . Participants in the predominantly psychotic group were characterized by a lower proportion of females, a lower age at baseline, a lower age at illness onset, a higher proportion of single (never married) individuals and were more frequently treated as inor daypatients compared to the predominantly affective group. In addition, fewer participants in the predominantly psychotic group reported a family history of psychiatric illness. Descriptive cross-sectional differences between sexes are summarized in Table 2 . Exemplary, the longitudinal course of acute depressive (IDS-C 30 ) symptoms over the study period is shown in Figure 1 . Analogously, courses of manic (YMRS) and psychotic Linear mixed model analyses of depressive symptoms (Table 3) reveal effects of in-or daypatient status at study inclusion (mean IDS- Figure 2 ) differed over time (mean YMRS scores at T1-T4: 3.0, 2.1, 2.5, 2.1), behaved differently in diagnostic groups over time and were independent of in-or daypatient status at baseline. Psychotic symptoms ( Regarding symptoms, the most prominent difference between both diagnostic groups is the magnitude of psychotic symptoms (Supporting Information Figure 3) . In both groups, there is a decrease of impairment after the baseline assessment and toward the end of the study period.
Analyses of GAF values over time (Table 6 ; for post hoc tests see Supporting Information Table 5 ) revealed effects of in-or daypatient status, diagnostic group, time and the sex 3 diagnostic group interaction. Mean GAF values at T1-T4 (Supporting Information Figure 4 ) 
| Genetic analyses of population structure
Supporting Information Figure 5 shows the PsyCourse subjects and all 1000 genomes super-populations based on the first two ancestry principal components and highlights the European origin of most of the subjects of the PsyCourse study.
| SZ-PRS analyses of the diagnostic group
A subset of 771 participants with available SZ-PRS and without missing data in any of the covariates was analyzed. Approximately 57.3% suffered from predominantly psychotic symptoms while 42.7% suffered from predominately affective symptoms. Figure 2 shows changes in Nagelkerke's R 2 due to effects of the SZ-PRS at 11 different p-value thresholds. Along with the increase of the SZ-PRS, the odds of being in the predominantly psychotic group increase. The largest effect was observed for the SZ-PRS at the p-value threshold of .05 (OR 5 1.28; 95% CI: 1.10-1.50). Table 4 . Table 4 .
| Analyses of follow-up study participation
Logistic regression was performed in 498 participants without missing data in the phenotypic predictors, 69.5% of whom had follow-up data from at least one additional study visit. Detailed results can be found in Supporting Information Table 6 . In the baseline model, that is, without any information from phenotypic predictors, 69.5% of the subjects were correctly classified. This rate increased to 73.5% when demographic and disease related variables (for details see Section 2.2.6) were entered in the regression model. Nagelkerke's R 95% CI: 0.17-0.60) were significantly associated with decreasing odds of having follow-up data. The age x sex interaction also had a significant effect in the model (p 5 .049; OR 5 1.04; 95% CI: 1.00-1.08). While in both female and male participants older age was associated with increasing odds of having follow-up data, this age effect was slightly stronger in females.
For the SZ-PRS analyses, a subsample of 613 subjects with SZ-PRS and completely available covariates was analyzed, 71.9% of whom had follow-up data. Figure 3 shows changes in Nagelkerke's R 2 due to effects of the SZ-PRS at 11 different p-value thresholds. As the SZPRSs increase, the odds of being in the follow-up group decrease. This trend was significant after FDR correction for risk scores at two differ- 
| D ISC USSION
Here, we present and provide an initial characterization of the PsyCourse study, a transdiagnostic study of the affective-to- (Murray et al., 2004) . Our analyses highlight mild depressive symptoms in both clinical groups that do not vary over time or show different patterns over time according to diagnostic group. Overall, females had slightly higher depression scores than men at baseline, an effect also observed in samples containing individuals suffering from either BD (Parker, Fletcher, Paterson, Anderson, & Hong, 2014) or SZ (Abel, Drake, & Goldstein, 2010) .
Psychotic symptoms, the symptom dimension that, predictably, showed the largest difference between diagnostic groups, decreased in both groups after the first study visit. This may be interpreted as common treatment effect, as many clinical participants were treated as in-or day patients at the beginning of the study. Manic symptom ratings did not vary between diagnostic groups but showed a different fluctuating pattern over time between predominantly psychotic and predominantly affective groups. Similar to symptoms of depression, symptoms of mania were observed in both diagnostic groups and illustrate symptom overlap between diagnostic groups. The different behavior over time of symptoms of mania in the diagnostic groups is thought to reflect the episodic characteristics of BD (Judd et al., 2002) . The sex effect observed across diagnostic groups in depression scores (higher IDS-C 30 scores in females) has neither been reported for SZ (Zisook et al., 1999) nor BD (Diflorio & Jones, 2010) and highlights new findings that may emerge when assessing symptom dimensions across diagnostic boundaries.
In summary, both mild depressive symptoms and symptoms of mania were comparable between diagnostic groups, whereas large differences in psychotic symptoms were the primary characteristic separating both diagnostic groups. Furthermore, we highlight a sex-specific pattern of more severe symptoms of depression in women suffering from severe mental disorders.
| Effects on psychosocial functioning
GAF values covary with symptom status by definition, a strong effect of in-or day patient status is therefore not surprising and does, of course, not imply causality. In addition, the pronounced difference in GAF values between diagnostic groups may be attributed to a more severe load of psychotic symptoms in the predominantly psychotic group. Analogous to the improvement of psychotic symptoms, we also interpret the GAF improvement over time in both diagnostic subgroups as treatment effect. The finding of a statistical interaction between sex and diagnostic group has been observed before when comparing psychotic and affective illnesses (Gade et al., 2015; Heilbronner et al., 2016) , reflecting psychotic females to have higher GAF scores than psychotic males, whereas no such sex difference exists in BD.
| SZ-PRS analyses of diagnostic group
We explored whether SZ-PRS are able to differentiate between predominantly psychotic versus affective participants in the PsyCourse study. The results are in line with knowledge of not only an overlapping (Purcell et al., 2009 ) but also a specific (Ruderfer et al., 2014) 
| SZ-PRS analyses of follow-up participation
In the current snapshot of the database, about 70% of the study participants have follow-up data for at least one study visit during the entire 18 months study period. Gender and the treatment at baseline were associated with dropout. More precisely, being male as well as being treated as an outpatient at baseline increased the odds of having follow-up data. An effect of age was only significant in interaction with sex. While in both female and male participants older age was associated with increasing odds of having follow-up data, this age effect was slightly more pronounced in females. Effect sizes of the significant predictors are small and the rate of correctly classified subjects only improved by 4% in comparison to the baseline model. However, the largest effects were observed for in-versus outpatient treatment at baseline. The selective dropout of hospitalized, hence more severely impaired, participants must be considered when interpreting longitudinal data from the PsyCourse study.
In the present study, associations between SZ-PRS and dropout were much lower compared to the findings from Martin et al. (2016) in the population-based Avon Longitudinal Study of Parents and Children (ALSPAC). However, a trend in the expected direction with significant effects for risk scores at two different p-value thresholds was observed. Since the current sample of the PsyCourse study is considerably smaller than the ALSPAC sample with nearly 8,000 subjects, the main reason for the lack of significant findings is presumably lower statistical power. Nevertheless, the results in the present study appear promising and, as recruitment is ongoing, analyses may be repeated using a larger sample in the future. To our knowledge, there is no comparable investigation in a clinical sample yet.
| Limitations of the present study
Here, we present the PsyCourse study and provide an overall characterization of the clinical study sample to illustrate its usefulness in future biological-psychiatric studies. Therefore, our results are exploratory and should to be treated as such. Furthermore, we did not include medication data in the present analysis. This information will be subject of future studies of the PsyCourse sample. Furthermore, the limited follow-up period of 18 months should be considered. While a longer period of time would be desirable to study the long-term course of severe mental illnesses, prospective samples of chronic patients suitable for biological studies on disease course are scarce. While we think that studies on the short-term course will uncover important mechanisms of severe mental disorders, the PsyCourse study can provide a resource for future longitudinal studies.
| Resource for collaborations
The PsyCourse study constitutes a unique resource on different levels. 
